Ignite Creation Date:
2025-12-24 @ 5:00 PM
Ignite Modification Date:
2025-12-29 @ 5:41 PM
Study NCT ID:
NCT03573050
Status:
COMPLETED
Last Update Posted:
2018-08-21
First Post:
2018-05-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase
Sponsor:
SocraTec R&D GmbH
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
1351riv18ct
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |